SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
0.888
-0.010 (-1.11%)
At close: Dec 20, 2024, 4:00 PM
0.950
+0.062 (6.98%)
After-hours: Dec 20, 2024, 7:47 PM EST

SLS Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
62.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20221.00M-6.60M-86.84%
Dec 31, 20217.60M5.70M300.00%
Dec 31, 20201.90M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.09B
OptiNose 75.67M
Burning Rock Biotech 72.83M
InterCure 72.42M
Cryo-Cell International 31.84M
Forian 19.71M
IceCure Medical 3.67M
BeyondSpring 1.88M
Revenue Rankings